Researchers & Partners

                          Our vision is to discover, develop and deliver transformational medicines for patients through our internal discovery efforts and innovative collaborations and strategic business development opportunities.

                          What We're Focused On

                          What We're Focused On

                          We concentrate our research and development efforts on our core therapeutic areas, and are pursuing multiple drug platforms for each.
                          In the Pipeline

                          In The Pipeline

                          View the entire pipeline or customize your search by area of disease, development phase or modality.

                          Investigating Combinations in Cancer Research

                          Investigating Combinations in Cancer Research


                          Our Research & Development Team

                          Our Research & Development Team

                          Our people are dedicated to unlocking the potential of innovative science. Our curiosity, persistence and desire to solve complex problems allow us to pursue our goal of delivering transformational medicines to patients.
                          Our Research and Development Facilities

                          Our Research and Development Facilities

                          Take a look at the worldwide network of state-of the-art facilities where our discovery and development work happens.


                          Partnering

                          Partnering

                          We actively seek partners with access to cutting-edge science that complements the innovation coming out of our own labs. Our business development team collaborates with R&D and organizations around the world to develop transformational medicines.


                          Researcher Resources

                          Independent Research

                          Independent Research

                          Bristol Myers Squibb wishes to advance science through supporting novel, independent research that addresses unmet need surrounding our products and therapeutic areas.

                          Clinical Trials

                          Clinical Trials

                          In 2017, we invested $4.8 billion* in R&D which included the discovery and development of new medicines for patients.

                          *This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items.?

                          Evan Janovitz

                          Input at Every Stage of Discovery

                          Evan Janovitz leads a team of veterinary pathologists and allied scientists in the Discovery Toxicology organization.
                          91精品国产在线观看